C12N 2770/14011
Bromoviridae
C12N2770/14011 (Bromoviridae) appears on 42 US grants and 53 published applications in this corpus.
Search patents in C12N- Granted patents
- 42
- Published applications
- 53
- Assignees
- 42
- Inventors
- 121
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 2 |
| 2005 | 1 | 3 |
| 2006 | 2 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 4 |
| 2012 | 1 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 2 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 3 | 6 |
| 2021 | 4 | 3 |
| 2022 | 3 | 4 |
| 2023 | 1 | 2 |
| 2024 | 0 | 4 |
| 2025 | 2 | 8 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/14022New viral proteins or individual genes, new structural or functional aspects ofIndexing code29
- C12N 2770/14023Virus like particles [vlp]Indexing code17
- C12N 2770/14041Use of virus, viral particle or viral elements as a vectorIndexing code7
- C12N 2770/14034Use of virus or viral component as vaccineIndexing code6
- C12N 2770/14021Viruses as suchIndexing code3
- C12N 2770/14033Use of viral protein as therapeutic agent other than vaccineIndexing code2
- C12N 2770/14031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2770/14032Use of virus as therapeutic agent, other than vaccineIndexing code0
Recent patents
- Modified virus-like particles of CMV21 Apr 2026US 12,605,454 B2Saiba GmbH
- Treatment of insect bite hypersensitivity18 Feb 2025US 12,226,475 B2UniversitäT ZüRich
- Plant viral RNA delivery nanoparticles and uses thereof21 Jan 2025US 12,203,073 B2Case Western Reserve University
- Covalently fused viral coat proteins for the display of target molecules4 Apr 2023US 11,618,771 B2Fraunhofer USA, Inc.
- Treatment of insect bite hypersensitivity12 Jul 2022US 11,382,970 B2UniversitäT ZüRich
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Compounds for rna stabilisation and delivery23 Jul 2026US 2026/0209277 A1Stichting VU
- Veterinary compositions of modified virus-like particles of cmv and ngf antigens12 Mar 2026US 2026/0069668 A1
- Modified virus-like particles of cmv26 Feb 2026US 2026/0055428 A1Saiba Animal Health AG
- Treatment of insect bite hypersensitivity4 Dec 2025US 2025/0367273 A1UniversitäT ZüRich
Most cited
By later US patents
- Hybrid RNA virus56US 5,602,242 AMycogen Plant Science, Inc. · 1997
- Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins45US 6,042,832 AThomas Jefferson University · 2000
- Hybrid RNA virus31US 5,627,060 AMycogen Plant Science, Inc. · 1997
- Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules25US 6,180,389 B2The Research and Development Institute, Inc. · 2001
- Cucumber mosaic virus coat protein gene24US 5,349,128 AThe Upjohn Company · 1994